UK begins human trials of Ebola vaccine developed in just eight weeks

The UK medicines regulator has approved human trials of an experimental Ebola vaccine that was developed in just eight weeks. The trials will be conducted on healthy adult volunteers. This marks the first clinical testing phase to assess the vaccine's safety and efficacy.